Viewing Study NCT03516760


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-02-11 @ 7:39 AM
Study NCT ID: NCT03516760
Status: TERMINATED
Last Update Posted: 2022-09-29
First Post: 2018-04-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia
Sponsor: AvenCell Europe GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Relapsed AML View
None Refractory AML View
Keywords: